Invesco Dynamic Biotechnology & Gen... (PBE)
$57.3533
+0.86 (+1.52%)
Rating:
Recommendation:
-
| Symbol | PBE |
|---|---|
| Price | $57.3533 |
| Beta | 0.820 |
| Volume Avg. | 0.01M |
| Market Cap | 260.957M |
| Shares () | - |
| 52 Week Range | 52.47-68.5 |
| 1y Target Est | - |
| DCF Unlevered | PBE DCF -> | |
|---|---|---|
| DCF Levered | PBE LDCF -> | |
| ROE | 9.54% | Neutral |
| ROA | 8.27% | Neutral |
| Operating Margin | - | |
| Debt / Equity | - | |
| P/E | 15.20 | Strong Buy |
| P/B | 0.92 | Buy |
Latest PBE news
About
Download (Excel)The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.